Table 2 Patient characteristics Neonatal CLD-CDH cohort (Rotterdam).

From: Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia

n

 

21

GA (weeks)

 

38.0 (33.6–41.3)

Gender (female/male)

 

(14/7)

Death

 

6 (28.6%)

Early-onset infection (EOI)

No

17 (81%)

 

Yes

4 (19%)

Mechanical ventilation

No

8 (38.1%)

 

Yes

10 (47.6%)

 

NA

3 (14.3%)

O2 (day 28)

No

6 (28.6%)

 

Yes

10 (47.6%)

 

NA

2 (9.5%)

Severity CLD

No CLD

6 (28.6%)

 

Mild CLD

8 (38.1%)

 

Severe CLD

1 (4.8%)

PH (first echocardiogram)

No

6 (28.6%)

 

PH (from 2/3 of syst. pressure on)

14 (66.7%)

 

NA

1 (4.8%)

ECMO

No

13 (61.9%)

 

Yes

8 (38.1%)

iNO

No

11 (52.4%)

 

Yes

10 (47.6%)

  1. Data are given as median and range or number and percent of total in group’s respective range.
  2. CLD chronic lung disease, ECMO extra corporal membrane oxygenation, EOI early-onset infection, GA gestational age, iNO inhalative nitric oxide, NA not available, PH pulmonary hypertension.
Back to article page